PowerHeal's one-of-a-kind bioelectric bandage represents a transformative leap, employing advanced technology to accelerate healing and minimize infection risk with unparalleled efficacy.
Vomaris announces the launch of its FDA-cleared PowerHeal bandage for over-the-counter use. (Credit: PRNewswire/Vomaris)
Vomaris, a pioneer in bioelectric wound care technology, announces the launch of its FDA-cleared PowerHeal™ bioelectric bandage for over-the-counter (OTC) use, marking a significant advancement in consumer wound care. Unlike traditional wound care products, PowerHeal’s one-of-a-kind bioelectric bandage represents a transformative leap, employing advanced technology to accelerate healing and minimize infection risk with unparalleled efficacy.
PowerHeal’s bioelectric bandages are powered by patented microcell battery technology. Foundationally inspired by the body, PowerHeal technology mimics the electrical energy (known as Transepithelial Potential) that skin naturally creates and uses to heal itself. This revolutionary approach not only creates an optimal healing environment by maintaining moisture, it provides crucial antibacterial protection and introduces a new dimension of care, by generating electricity through moisture-activated microcell batteries that are embedded within PowerHeal bandages.
PowerHeal does more than just cover a wound like traditional bandages, it helps heal it. Multiple published scientific and clinical studies have demonstrated its ability to accelerate the movement of healing cells across the wound surface and to effectively kill up to 99.99% of bacteria without the use of antibiotics, to help heal wounds by 2-3 times faster.
“PowerHeal is proud to bring medical-grade wound care technology directly into the hands of consumers,” said Michael Nagel, President & CEO of Vomaris Innovations, Inc. “Our bioelectric products are designed to empower people to take charge of their healing by delivering fast, safe, and effective advanced wound care at home.”
This innovation is a game-changer for individuals facing a spectrum of acute and chronic wounds, including cuts, scrapes, large abrasions like road rash and turf burn, burn wounds, surgical incisions, and challenging wounds such as those from diabetes or ulcers resulting from venous disease.
With approximately 6.5 million Americans treated for chronic wounds each year1, an estimated 3.6 million people suffering from diabetes-related wounds2, and surgical site infections affecting 1.5 million people each year in the US alone3, the need for effective advanced wound care is significant.
Now more than ever before, patients are empowered consumers that are taking control over how, when, and in what manner they receive care. The global advanced wound care market is valued at $14 billion in 2024, and is predicted to surpass $45 billion by 2032,4 largely driven by diabetes, obesity, and the aging population. PowerHeal exists not only to further empower the 10 million plus patients with acute and chronic wounds, but also to give all wound care consumers the ability to take charge of their healing.
“With nearly a decade of success in the prescription surgical and wound care markets, PowerHeal’s technology has treated over one million wounds to-date,” emphasized Mary Maijer, Chief Commercial Officer of Vomaris Innovations, Inc. “Bringing this clinically-proven product to consumers is in direct response to the expressed need to make well-substantiated wound care products more broadly available.”
Consumers can now access PowerHeal’s bioelectric bandages at powerhealwounds.com and on Amazon, offering convenient at-home wound care. With a variety of sizes, and no-adhesive and adhesive options available, ranging from $5 to $14 per bandage, individuals can find the right fit for their needs, whether addressing acute injuries or managing chronic conditions.
Source: Company Press Release